Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Grown Rogue International Inc. publishes a filing, an earnings call transcript or a press release.
Get GRUSF alertsAndrew Marchington is recorded as CFO at Grown Rogue International Inc. (GRUSF). The proxy statement of Grown Rogue International Inc. reports total compensation of $705,926 for Andrew Marchington in fiscal 2025, including a base salary of $252,866. Disclosed compensation is on record for 2 fiscal years. Andrew Marchington has spoken on 2 earnings calls across 1 company, most recently for Grown Rogue International Inc. on August 4, 2026. Grown Rogue International Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Grown Rogue International Inc. includes J. Obie Strickler (CEO) and Ryan Kee (CFO).
“So with that, I'll hand it over to Josh. Excuse me. Thanks, Obi.”
“Well, 2025 was our first year here, at least the first full year reported under US GAAP. So, as noted, we undertook an IFRS to US GAAP conversion process.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Grown Rogue International Inc. (GRUSF) | Chief Financial Officer | $252,866 | $705,926 |
| 2024 | Grown Rogue International Inc. (GRUSF) | Chief Financial Officer | — | — |